Interpharm signs agreement with Centrix |
|
|
|
Published
:
Mon, 16 Apr 2007 22:05
|
BIRMINGHAM, Ala. (AP) - Centrix Pharmaceutical Inc. said Monday it will sell and distribute pain relief tablets made by Interpharm Holdings Inc.Details of the agreement were not disclosed, but privately held Centrix said Interpharm will receive a portion of the profits generated from sales of the Reprexain, a combination drug that includes ibuprofen and hydrocodone. The companies will offer Reprexain in four separate doses.Shares of Interpharm Holdings Inc. closed unchanged at $1.50 on the American Stock Exchange.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2251.69 |
-12.87 (
-0.56 %)
|
| SYMBOL (
2010-07-29 ) |
| LAST |
CHANGE
|
|
KAZAKHMYS
(
11:37am )
|
|
1220.00 |
+23.00 (
1.91 %)
|
|
LONMIN
(
11:35am )
|
|
1580.00 |
+21.00 (
1.35 %)
|
|
SHIRE
(
11:35am )
|
|
1490.00 |
+21.00 (
1.43 %)
|
| SYMBOL (
2010-07-29 )
|
| LAST |
CHANGE
|
|
DUPONT
(
4:00pm ) |
|
40.51 |
+0.24 (
0.59 %)
|
| SYMBOL (
2010-07-29 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Interpharm CFO resigns 